Advertisement

More articles from Research Article

  • ERPAS to predict response to endocrine therapy
    Marcia A. Inda, Erik J. Blok, Peter J.K. Kuppen, Ayoub Charehbili, Eveline C den Biezen-Timmermans, Anne van Brussel, Sevgi E. Fruytier, Elma Meershoek - Klein Kranenbarg, Susan L. Kloet, Bart van der Burg, John W.M. Martens, Andrew H. Sims, Arran K Turnbull, J Michael Dixon, Wim Verhaegh, Judith R. Kroep, Cornelis J.H. van de Velde, Anja van de Stolpe
    Molecular Cancer Therapeutics Jan 2019, molcanther.0318.2019; DOI: 10.1158/1535-7163.MCT-19-0318
  • DS-1001b suppresses the growth of IDH1 mutant glioblastoma
    Yukino Machida, Makoto Nakagawa, Hironori Matsunaga, Masayuki Yamaguchi, Yoko Ogawara, Yutaka Shima, Kazutsune Yamagata, Takuo Katsumoto, Ayuna Hattori, Masao Itoh, Takahiko Seki, Yumi Nishiya, Koichi Nakamura, Kanae Suzuki, Tomoki Imaoka, Daichi Baba, Makoto Suzuki, Oltea Sampetrean, Hideyuki Saya, Koichi Ichimura, Issay Kitabayashi
    Molecular Cancer Therapeutics Jan 2019, molcanther.1349.2018; DOI: 10.1158/1535-7163.MCT-18-1349
  • Selective PRMT5 inhibitors suppress human CD8+ T-cells
    Carolin Dorothea Strobl, Stefanie Schaffer, Tabea Haug, Simon Völkl, Katrin Peter, Katrin Singer, Martin Böttcher, Dimitrios Mougiakakos, Andreas Mackensen, Michael Aigner
    Molecular Cancer Therapeutics Jan 2019, molcanther.0189.2019; DOI: 10.1158/1535-7163.MCT-19-0189
  • Re-sensitizing taxane-resistant CRPC by RORγ inhibitors
    Yongqiang Wang, Zenghong Huang, Christopher Z. Chen, Chengfei Liu, Christopher P Evans, Allen C. Gao, Fangjian Zhou, Hong-Wu Chen
    Molecular Cancer Therapeutics Jan 2019, molcanther.0327.2019; DOI: 10.1158/1535-7163.MCT-19-0327
  • WEE1 inhibition sensitizes MPM to chemotherapy
    Duo Xu, Shun-Qing Liang, Haitang Yang, Rémy Bruggmann, Sabina Berezowska, Zhang Yang, Thomas Michael Marti, Sean Ralph Robert Hall, Yanyun Gao, Gregor J Kocher, Ralph A Schmid, Ren-Wang Peng
    Molecular Cancer Therapeutics Jan 2019, molcanther.0724.2019; DOI: 10.1158/1535-7163.MCT-19-0724
  • Targeting Hyaluronan in PDAC using Recombinant Salmonella
    Nancy D Ebelt, Edith Zuniga, Kevin B. Passi, Lukas J. Sobocinski, Edwin R. Manuel
    Molecular Cancer Therapeutics Jan 2019, molcanther.0556.2019; DOI: 10.1158/1535-7163.MCT-19-0556
  • SGK1 promotes bone metastasis of breast cancer
    Zheng Zhang, Qian Xu, Chao Song, Baoguo Mi, Honghua Zhang, Honglei Kang, Huiyong Liu, Yunlong Sun, Jia Wang, Zhuowei Lei, Hanfeng Guan, Feng Li
    Molecular Cancer Therapeutics Jan 2019, molcanther.0783.2018; DOI: 10.1158/1535-7163.MCT-18-0783
  • VEGF/Akt radioprotects 3D glioblastoma cells through NHEJ
    Natividad Gomez-Roman, Ming Y Chong, Sandeep K Chahal, Seamus P Caragher, Mark R Jackson, Katrina H. Stevenson, Sidhartha A. Dongre, Anthony J. Chalmers
    Molecular Cancer Therapeutics Jan 2019, molcanther.1320.2018; DOI: 10.1158/1535-7163.MCT-18-1320
  • YB1 inhibition suppresses cell growth and motility in CRC
    Areumnuri Kim, Sehwan Shim, Young-heon Kim, Min-Jung Kim, Sunhoo Park, Jae Kyung Myung
    Molecular Cancer Therapeutics Jan 2019, molcanther.0265.2019; DOI: 10.1158/1535-7163.MCT-19-0265
  • Reverse radioresistance of cervical cancer with PIK3CA E545K
    Wei Jiang, Yutuan Wu, Tiancong He, Hanting Zhu, Guihao Ke, Libing Xiang, Huijuan Yang
    Molecular Cancer Therapeutics Jan 2019, molcanther.0309.2019; DOI: 10.1158/1535-7163.MCT-19-0309

Pages